JP2005533064A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005533064A5 JP2005533064A5 JP2004513253A JP2004513253A JP2005533064A5 JP 2005533064 A5 JP2005533064 A5 JP 2005533064A5 JP 2004513253 A JP2004513253 A JP 2004513253A JP 2004513253 A JP2004513253 A JP 2004513253A JP 2005533064 A5 JP2005533064 A5 JP 2005533064A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- phenyl
- itself
- hydroxy
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 cyano, hydroxy Chemical group 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 13
- 150000002367 halogens Chemical class 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 102000003847 Carboxypeptidase B2 Human genes 0.000 claims 4
- 108090000201 Carboxypeptidase B2 Proteins 0.000 claims 4
- 125000005958 tetrahydrothienyl group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000003507 tetrahydrothiofenyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201837A SE0201837D0 (sv) | 2002-06-14 | 2002-06-14 | Chemical compounds |
| PCT/SE2003/000970 WO2003106420A1 (en) | 2002-06-14 | 2003-06-10 | 2,5-disubstituted 3-mercaptopentanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005533064A JP2005533064A (ja) | 2005-11-04 |
| JP2005533064A5 true JP2005533064A5 (https=) | 2006-07-06 |
Family
ID=20288202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004513253A Withdrawn JP2005533064A (ja) | 2002-06-14 | 2003-06-10 | ２，５−ジ置換３−メルカプトペンタン酸 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7572817B2 (https=) |
| EP (1) | EP1532111B1 (https=) |
| JP (1) | JP2005533064A (https=) |
| KR (1) | KR20050010051A (https=) |
| CN (1) | CN100415719C (https=) |
| AR (1) | AR040240A1 (https=) |
| AT (1) | ATE369342T1 (https=) |
| AU (1) | AU2003241260B2 (https=) |
| BR (1) | BR0311384A (https=) |
| CA (1) | CA2488606A1 (https=) |
| CY (1) | CY1107753T1 (https=) |
| DE (1) | DE60315471T2 (https=) |
| DK (1) | DK1532111T3 (https=) |
| ES (1) | ES2289297T3 (https=) |
| IS (1) | IS7609A (https=) |
| MX (1) | MXPA04012604A (https=) |
| MY (1) | MY160429A (https=) |
| NO (1) | NO20045051L (https=) |
| NZ (1) | NZ536814A (https=) |
| PL (1) | PL373883A1 (https=) |
| PT (1) | PT1532111E (https=) |
| RU (1) | RU2365583C2 (https=) |
| SA (1) | SA03240142B1 (https=) |
| SE (1) | SE0201837D0 (https=) |
| TW (1) | TW200401766A (https=) |
| UA (1) | UA78042C2 (https=) |
| WO (1) | WO2003106420A1 (https=) |
| ZA (1) | ZA200409955B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7276497B2 (en) * | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| GB0403864D0 (en) * | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
| CA2600869A1 (en) | 2005-03-18 | 2006-09-28 | The Regents Of The University Of California | Compounds having activity in correcting mutant-cftr processing and uses thereof |
| NZ592764A (en) | 2008-10-29 | 2012-08-31 | Taisho Pharmaceutical Co Ltd | Compound having tafia inhibitory activity |
| AP2011005795A0 (en) | 2009-02-13 | 2011-08-31 | Boehringer Ingelheim Int | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia. |
| HRP20190101T1 (hr) | 2013-04-05 | 2019-03-08 | Boehringer Ingelheim International Gmbh | Terapeutske uporabe empagliflozina |
| US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| FI4000608T3 (fi) | 2013-04-18 | 2026-01-21 | Boehringer Ingelheim Int | Farmaseuttinen koostumus, menetelmä hoitamiseksi ja sen käyttöjä |
| CA2914533A1 (en) | 2013-06-10 | 2014-12-18 | Sanofi | Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals |
| KR20250097990A (ko) | 2016-11-10 | 2025-06-30 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000066577A2 (en) * | 1999-04-29 | 2000-11-09 | Allergan Sales, Inc. | Brigded cycloalkanes as thromboxane ligands without blood clotting effects |
| SE9901573D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
-
2002
- 2002-06-14 SE SE0201837A patent/SE0201837D0/xx unknown
-
2003
- 2003-06-02 AR ARP030101959A patent/AR040240A1/es unknown
- 2003-06-08 SA SA03240142A patent/SA03240142B1/ar unknown
- 2003-06-10 CN CNB038138409A patent/CN100415719C/zh not_active Expired - Fee Related
- 2003-06-10 ES ES03730987T patent/ES2289297T3/es not_active Expired - Lifetime
- 2003-06-10 KR KR10-2004-7020285A patent/KR20050010051A/ko not_active Ceased
- 2003-06-10 AT AT03730987T patent/ATE369342T1/de not_active IP Right Cessation
- 2003-06-10 PT PT03730987T patent/PT1532111E/pt unknown
- 2003-06-10 PL PL03373883A patent/PL373883A1/xx not_active Application Discontinuation
- 2003-06-10 EP EP03730987A patent/EP1532111B1/en not_active Expired - Lifetime
- 2003-06-10 AU AU2003241260A patent/AU2003241260B2/en not_active Ceased
- 2003-06-10 US US10/517,713 patent/US7572817B2/en not_active Expired - Fee Related
- 2003-06-10 DE DE60315471T patent/DE60315471T2/de not_active Expired - Fee Related
- 2003-06-10 RU RU2004134563/04A patent/RU2365583C2/ru not_active IP Right Cessation
- 2003-06-10 NZ NZ536814A patent/NZ536814A/en unknown
- 2003-06-10 MX MXPA04012604A patent/MXPA04012604A/es active IP Right Grant
- 2003-06-10 JP JP2004513253A patent/JP2005533064A/ja not_active Withdrawn
- 2003-06-10 DK DK03730987T patent/DK1532111T3/da active
- 2003-06-10 BR BR0311384-1A patent/BR0311384A/pt not_active IP Right Cessation
- 2003-06-10 CA CA002488606A patent/CA2488606A1/en not_active Abandoned
- 2003-06-10 WO PCT/SE2003/000970 patent/WO2003106420A1/en not_active Ceased
- 2003-06-12 TW TW092115988A patent/TW200401766A/zh unknown
- 2003-06-12 MY MYPI20032192A patent/MY160429A/en unknown
- 2003-10-06 UA UA20041109447A patent/UA78042C2/uk unknown
-
2004
- 2004-11-19 NO NO20045051A patent/NO20045051L/no not_active Application Discontinuation
- 2004-12-08 ZA ZA200409955A patent/ZA200409955B/en unknown
- 2004-12-22 IS IS7609A patent/IS7609A/is unknown
-
2007
- 2007-10-08 CY CY20071101274T patent/CY1107753T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006509749A5 (https=) | ||
| JP2005533064A5 (https=) | ||
| JP2006524222A5 (https=) | ||
| JP2007532474A5 (https=) | ||
| JP2003520195A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2005502635A5 (https=) | ||
| JP2004532266A5 (https=) | ||
| CA2507545A1 (en) | Use of furfural derivatives as anti-sickling agents | |
| JP2021046404A5 (https=) | ||
| JP2006507220A5 (https=) | ||
| JP2007502295A5 (https=) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2007507494A5 (https=) | ||
| JPS5995269A (ja) | 抗てんかん性医薬品 | |
| RU2004134563A (ru) | 2,5-дизамещенная 3-меркаптопентановая кислота | |
| JP2005526024A5 (https=) | ||
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| RU2004111601A (ru) | Пиперидиновые производные и их применение в качестве модуляторов активности р ецепторов хемокина (в частности ccr5) | |
| JP2007502817A5 (https=) | ||
| JP2009541387A5 (https=) | ||
| JP2005517677A5 (https=) | ||
| RU2002113450A (ru) | Кристаллическая форма (S)-2-этокси-3-[4-(2-{4-метансульфонилоксифенил}этокси)фенил]пропановой кислоты | |
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| US20030027844A1 (en) | Pharmaceutical compositions for ulcer |